The Oncologist http://theoncologist.alphamedpress.org/misc/eLetters.shtml
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

    Volume 12, Number 6, 2007   [Index by author] 

      Down ORIGINAL PAPERS
             Down BREAST CANCER
             Down ENDOCRINOLOGY
             Down GASTROINTESTINAL CANCER
             Down MYELOMAS
             Down RADIATION ONCOLOGY
             Down REGULATORY ISSUES: FDA
             Down SARCOMAS
             Down SYMPTOM MANAGEMENT AND SUPPORTIVE CARE
      Down REFLECTIONS

Cover Image
Other Issues:
Previous Next
Find articles in this issue containing these words:
[Search ALL Issues]


Receive this page by email each issue: [Sign up for eTOCs]
To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.



Back   ORIGINAL PAPERS

 Back   BREAST CANCER

An Association Between RRM1 Haplotype and Gemcitabine-Induced Neutropenia in Breast Cancer Patients
Sun Young Rha, Hei Cheul Jeung, Yeon Ho Choi, Woo Ick Yang, Jin Ho Yoo, Byung Soo Kim, Jae Kyung Roh, Hyun Cheol Chung
The Oncologist 2007; 12: 622-630; doi:10.1634/theoncologist.12-6-622
[Abstract] [Full Text] [PDF]  
Development and Clinical Utility of a 21-Gene Recurrence Score Prognostic Assay in Patients with Early Breast Cancer Treated with Tamoxifen
Soonmyung Paik
The Oncologist 2007; 12: 631-635; doi:10.1634/theoncologist.12-6-631
[Abstract] [Full Text] [PDF] CME  
Changes in and Prognostic Value of Hormone Receptor Status in a Series of Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Olivier Tacca, Frédérique Penault-Llorca, Catherine Abrial, Marie-Ange Mouret-Reynier, Inès Raoelfils, Xavier Durando, Jean-Louis Achard, Pierre Gimbergues, Hervé Curé, Philippe Chollet
The Oncologist 2007; 12: 636-643; doi:10.1634/theoncologist.12-6-636
[Abstract] [Full Text] [PDF]  

 Back   ENDOCRINOLOGY
Primary Hyperparathyroidism
James W. Suliburk, Nancy D. Perrier
The Oncologist 2007; 12: 644-653; doi:10.1634/theoncologist.12-6-644
[Abstract] [Full Text] [PDF] CME  

 Back   GASTROINTESTINAL CANCER
Extended Resection for Pancreatic Adenocarcinoma
Srinevas K. Reddy, Douglas S. Tyler, Theodore N. Pappas, Bryan M. Clary
The Oncologist 2007; 12: 654-663; doi:10.1634/theoncologist.12-6-654
[Abstract] [Full Text] [PDF] CME  

 Back   MYELOMAS
New Drugs for Myeloma
Paul G. Richardson, Constantine Mitsiades, Robert Schlossman, Nikhil Munshi, Kenneth Anderson
The Oncologist 2007; 12: 664-689; doi:10.1634/theoncologist.12-6-664
[Abstract] [Full Text] [PDF] CME  

 Back   RADIATION ONCOLOGY
Review: Implications of In Vitro Research on the Effect of Radiotherapy and Chemotherapy Under Hypoxic Conditions
An Wouters, Bea Pauwels, Filip Lardon, Jan B. Vermorken
The Oncologist 2007; 12: 690-712; doi:10.1634/theoncologist.12-6-690
[Abstract] [Full Text] [PDF] CME  

 Back   REGULATORY ISSUES: FDA
FDA Drug Approval Summary: Bevacizumab (Avastin®) Plus Carboplatin and Paclitaxel as First-Line Treatment of Advanced/Metastatic Recurrent Nonsquamous Non-Small Cell Lung Cancer
Martin H. Cohen, Joe Gootenberg, Patricia Keegan, Richard Pazdur
The Oncologist 2007; 12: 713-718; doi:10.1634/theoncologist.12-6-713
[Abstract] [Full Text] [PDF] CME  

 Back   SARCOMAS
Improved Insight into Resistance Mechanisms to Imatinib in Gastrointestinal Stromal Tumors: A Basis for Novel Approaches and Individualization of Treatment
Stefan Sleijfer, Erik Wiemer, Caroline Seynaeve, Jaap Verweij
The Oncologist 2007; 12: 719-726; doi:10.1634/theoncologist.12-6-719
[Abstract] [Full Text] [PDF] CME  

 Back   SYMPTOM MANAGEMENT AND SUPPORTIVE CARE
Efficacy and Safety of Every-2-Week Darbepoetin Alfa in Patients with Anemia of Cancer: A Controlled, Randomized, Open-Label Phase II Trial
Veena Charu, Chandra P. Belani, Ahmad N. Gill, Mukesh Bhatt, Dianne Tomita, Greg Rossi, Ali Ben-Jacob
The Oncologist 2007; 12: 727-737; doi:10.1634/theoncologist.12-6-727
[Abstract] [Full Text] [PDF]  
Amifostine: The First Selective-Target and Broad-Spectrum Radioprotector
John R. Kouvaris, Vassilis E. Kouloulias, Lampros J. Vlahos
The Oncologist 2007; 12: 738-747; doi:10.1634/theoncologist.12-6-738
[Abstract] [Full Text] [PDF] CME  
Prediction of the Responsiveness to Treatment with Erythropoiesis-Stimulating Factors: A Prospective Clinical Study in Patients with Solid Tumors
Tilman Steinmetz, Martin Hellmich, Michael Neise, Ali Aldaud, Christian Lerchenmüller, Antonis Tsamaloukas, Francoise Fandel, Christoph Weiligmann, Uwe Totzke, Stephan Schmitz
The Oncologist 2007; 12: 748-755; doi:10.1634/theoncologist.12-6-748
[Abstract] [Full Text] [PDF] [Supplemental Data]  

Back   REFLECTIONS
 Reflections
Kornelia Roth
The Oncologist 2007; 12: 3002-3003; doi:10.1634/theoncologist.12-6-6000
[Full Text] [PDF]  


To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.


Cover Illustration:Back

Cover

Oriental Poppy by Bernique Longley.

Laudanum, or tincture of opium, was for many decades the only "treatment" for cancer in the Old West; the Oriental Poppy has, therefore, been chosen as the journal's icon.



HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl

Copyright © 2007 by AlphaMed Press.